AI-assisted dog cancer vaccine startup seeks clinical-trial participants
Gamgee, a startup developing personalized cancer vaccines for dogs, has attracted backing from technology incubator Y Combinator. The company says it is recruiting participants for its first clinical trials in Australia. Elsewhere, it has opened a waiting list, while founder Paul Conyngham says Gamgee is also “accepting cases globally.”
On a section of its website for veterinarians, Gamgee reports an approximately 75 percent reduction in the tumor in what it calls its “first documented case.” The company says its process should take less than 20 minutes of a veterinarian’s time and should not require new clinical workflows. It also says a completed vaccine could be available in about four weeks.
Gamgee cautions that the four-week estimate is based on a single case and may differ in other situations. The company has not published costs on its website. The startup emerged after Conyngham described using ChatGPT, Grok and other AI tools while developing a personalized cancer vaccine for his dog.
Written by Sakhanda Wire AI from reporting by The Verge. Facts, quotes and full context are in the original article below.